{"&cites=11946046476018981343&as_sdt=2005&sciodt=0,5&hl=en":[{"title":"Membrane transporters in drug development","url":"https://www.nature.com/articles/nrd3028","authors":["KM Giacomini","KM Giacomini SM Huang","KM Giacomini SM Huang DJ Tweedie…"],"year":2010,"numCitations":2554,"pdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3326076/","citationUrl":"http://scholar.google.com/scholar?cites=14688406337086106108&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:_Cmdtr2z18sJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=14688406337086106108&hl=en&as_sdt=2005&sciodt=0,5","publication":"nature.com","p":1,"exp":1596894054314},{"title":"Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs","url":"https://www.nature.com/articles/nrd2197","authors":["CJH Porter","CJH Porter NL Trevaskis","CJH Porter NL Trevaskis WN Charman"],"year":2007,"numCitations":1445,"pdf":"https://www.researchgate.net/profile/Natalie_Trevaskis/publication/6476671_Lipids_and_lipid-based_formulations_Optimizing_the_oral_delivery_of_lipophilic_drugs/links/0c9605261fc5a122a8000000.pdf","citationUrl":"http://scholar.google.com/scholar?cites=7282930369136830305&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:YSdOiJUqEmUJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=7282930369136830305&hl=en&as_sdt=2005&sciodt=0,5","publication":"nature.com"},{"title":"Strategies to address low drug solubility in discovery and development","url":"http://pharmrev.aspetjournals.org/content/65/1/315.short","authors":["HD Williams","HD Williams NL Trevaskis","HD Williams NL Trevaskis SA Charman…"],"year":2013,"numCitations":961,"pdf":"https://www.researchgate.net/profile/Natalie_Trevaskis/publication/235402389_Strategies_to_Address_Low_Drug_Solubility_in_Discovery_and_Development/links/004635261fd3d98efe000000/Strategies-to-Address-Low-Drug-Solubility-in-Discovery-and-Development.pdf","citationUrl":"http://scholar.google.com/scholar?cites=17164111365420135558&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:hrQc9VgsM-4J:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=17164111365420135558&hl=en&as_sdt=2005&sciodt=0,5","publication":"ASPET"},{"title":"Formulation design for poorly water-soluble drugs based on biopharmaceutics classification system: basic approaches and practical applications","url":"https://www.sciencedirect.com/science/article/pii/S0378517311007940","authors":["Y Kawabata","Y Kawabata K Wada","Y Kawabata K Wada M Nakatani","Y Kawabata K Wada M Nakatani S Yamada…"],"year":2011,"numCitations":893,"citationUrl":"http://scholar.google.com/scholar?cites=7262534474501908398&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:rue2QaC0yWQJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=7262534474501908398&hl=en&as_sdt=2005&sciodt=0,5","publication":"Elsevier"},{"title":"Primary hepatocytes: current understanding of the regulation of metabolic enzymes and transporter proteins, and pharmaceutical practice for the use of hepatocytes in …","url":"https://www.tandfonline.com/doi/abs/10.1080/03602530601093489","authors":["NJ Hewitt","NJ Hewitt MJ Gómez Lechón","NJ Hewitt MJ Gómez Lechón JB Houston…"],"year":2007,"numCitations":705,"pdf":"https://www.academia.edu/download/31076932/Hewitt_et_al_2007.pdf","citationUrl":"http://scholar.google.com/scholar?cites=2716203220769705058&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:YgzAL3DksSUJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=2716203220769705058&hl=en&as_sdt=2005&sciodt=0,5","publication":"Taylor & Francis"},{"title":"A provisional biopharmaceutical classification of the top 200 oral drug products in the United States, Great Britain, Spain, and Japan","url":"https://pubs.acs.org/doi/abs/10.1021/mp0600182","authors":["T Takagi","T Takagi C Ramachandran","T Takagi C Ramachandran M Bermejo…"],"year":2006,"numCitations":533,"pdf":"http://pstorage-acs-6854636.s3.amazonaws.com/4748596/mp0600182_si_001.pdf","citationUrl":"http://scholar.google.com/scholar?cites=15925189217797057103&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:T6qs4zejAd0J:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=15925189217797057103&hl=en&as_sdt=2005&sciodt=0,5","publication":"ACS Publications"},{"title":"Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative …","url":"https://bmcmedgenomics.biomedcentral.com/articles/10.1186/1755-8794-2-2","authors":["DB Kell"],"year":2009,"numCitations":490,"pdf":"https://bmcmedgenomics.biomedcentral.com/articles/10.1186/1755-8794-2-2","citationUrl":"http://scholar.google.com/scholar?cites=435603683250223998&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:fjv78j2TCwYJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=435603683250223998&hl=en&as_sdt=2005&sciodt=0,5","publication":"bmcmedgenomics.biomedcentral …"},{"title":"Key factors in the discovery and development of new antiepileptic drugs","url":"https://www.nature.com/articles/nrd2997","authors":["M Bialer","M Bialer HS White"],"year":2010,"numCitations":482,"citationUrl":"http://scholar.google.com/scholar?cites=9780128776670308535&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:t2gCF07_uYcJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=9780128776670308535&hl=en&as_sdt=2005&sciodt=0,5","publication":"nature.com"},{"title":"Coexistence of passive and carrier-mediated processes in drug transport","url":"https://www.nature.com/articles/nrd3187","authors":["K Sugano","K Sugano M Kansy","K Sugano M Kansy P Artursson","K Sugano M Kansy P Artursson A Avdeef…"],"year":2010,"numCitations":465,"citationUrl":"http://scholar.google.com/scholar?cites=1215177958795207352&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:uGLfTOot3RAJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=1215177958795207352&hl=en&as_sdt=2005&sciodt=0,5","publication":"nature.com"},{"title":"BDDCS applied to over 900 drugs","url":"https://link.springer.com/article/10.1208/s12248-011-9290-9","authors":["LZ Benet","LZ Benet F Broccatelli","LZ Benet F Broccatelli TI Oprea"],"year":2011,"numCitations":454,"pdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3231854/","citationUrl":"http://scholar.google.com/scholar?cites=11359298234231681533&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:_fEZVY9VpJ0J:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=11359298234231681533&hl=en&as_sdt=2005&sciodt=0,5","publication":"Springer"}]}